GB202208849D0 - Dosage regime - Google Patents

Dosage regime

Info

Publication number
GB202208849D0
GB202208849D0 GBGB2208849.6A GB202208849A GB202208849D0 GB 202208849 D0 GB202208849 D0 GB 202208849D0 GB 202208849 A GB202208849 A GB 202208849A GB 202208849 D0 GB202208849 D0 GB 202208849D0
Authority
GB
United Kingdom
Prior art keywords
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2208849.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaptimmune Ltd
Original Assignee
Adaptimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adaptimmune Ltd filed Critical Adaptimmune Ltd
Priority to GBGB2208849.6A priority Critical patent/GB202208849D0/en
Publication of GB202208849D0 publication Critical patent/GB202208849D0/en
Priority to PCT/GB2023/051565 priority patent/WO2023242578A1/en
Ceased legal-status Critical Current

Links

GBGB2208849.6A 2022-06-16 2022-06-16 Dosage regime Ceased GB202208849D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2208849.6A GB202208849D0 (en) 2022-06-16 2022-06-16 Dosage regime
PCT/GB2023/051565 WO2023242578A1 (en) 2022-06-16 2023-06-15 Dosage regimen for a combination therapy consisting oftcr-engineered t-cells in combination with a pd-1 axis binding antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2208849.6A GB202208849D0 (en) 2022-06-16 2022-06-16 Dosage regime

Publications (1)

Publication Number Publication Date
GB202208849D0 true GB202208849D0 (en) 2022-08-10

Family

ID=82705695

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2208849.6A Ceased GB202208849D0 (en) 2022-06-16 2022-06-16 Dosage regime

Country Status (1)

Country Link
GB (1) GB202208849D0 (en)

Similar Documents

Publication Publication Date Title
GB2595776B (en) Therapeutic solid dosage forms
IL291452A (en) Dosage forms for tyk2 inhibitors
GB202020191D0 (en) Pharmaceutical compounds
GB202010409D0 (en) Pharmaceutical compounds
GB202213032D0 (en) Dosage regime
GB202212323D0 (en) Dosage regime
GB202208849D0 (en) Dosage regime
GB202200753D0 (en) Pharmaceutical compounds
GB202010408D0 (en) Pharmaceutical compounds
GB202316063D0 (en) Dosing regime
GB202304987D0 (en) Combination pharmaceutical
GB202216306D0 (en) Combination pharmaceutical
GB202203093D0 (en) Medicament
IL308389A (en) Dosage regimens for ecubectedin
IL289020A (en) Antibacterial dosage regime using cannabinoids
GB201808507D0 (en) Dosage Regime
GB201808473D0 (en) Dosage regime
GB201808101D0 (en) Dosage regime
GB202312534D0 (en) Pharmaceutical compounds
GB202311227D0 (en) Pharmaceutical compounds
GB202311018D0 (en) Pharmaceutical compounds
GB201803298D0 (en) Dosage regime
GB201802679D0 (en) Dosage regime
EP4098594A4 (en) Drug feeder
GB202319534D0 (en) Dosage regimen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)